IL134151A0 - Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity - Google Patents
Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavityInfo
- Publication number
- IL134151A0 IL134151A0 IL13415198A IL13415198A IL134151A0 IL 134151 A0 IL134151 A0 IL 134151A0 IL 13415198 A IL13415198 A IL 13415198A IL 13415198 A IL13415198 A IL 13415198A IL 134151 A0 IL134151 A0 IL 134151A0
- Authority
- IL
- Israel
- Prior art keywords
- controlled release
- oral cavity
- polymer compositions
- pharmaceutical agents
- tannic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89912197A | 1997-07-23 | 1997-07-23 | |
PCT/US1998/015096 WO1999004764A1 (en) | 1997-07-23 | 1998-07-22 | Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
Publications (1)
Publication Number | Publication Date |
---|---|
IL134151A0 true IL134151A0 (en) | 2001-04-30 |
Family
ID=25410514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13415198A IL134151A0 (en) | 1997-07-23 | 1998-07-22 | Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1003483A1 (en) |
JP (1) | JP2001510788A (en) |
KR (1) | KR20010021911A (en) |
AU (1) | AU8578498A (en) |
BR (1) | BR9811478A (en) |
CA (1) | CA2296654A1 (en) |
HU (1) | HUP0002490A2 (en) |
IL (1) | IL134151A0 (en) |
NO (1) | NO20000284L (en) |
WO (1) | WO1999004764A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
AU6872201A (en) * | 2000-06-23 | 2002-01-08 | Teva Pharma | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US7674480B2 (en) | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US6881420B2 (en) | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
ATE369184T1 (en) * | 2000-09-01 | 2007-08-15 | Cognis Ip Man Gmbh | ORAL AND DENTAL CARE PRODUCTS |
JP4820024B2 (en) * | 2001-01-10 | 2011-11-24 | 昭和薬品化工株式会社 | Local anesthetic composition |
JP5089840B2 (en) * | 2001-09-25 | 2012-12-05 | 救急薬品工業株式会社 | Nicotine-containing film preparation |
CN1309425C (en) * | 2001-11-05 | 2007-04-11 | 奥拉黑尔斯公司 | Treating canker sores with patches to speed healing and relieve pain |
AU2004220541B2 (en) * | 2003-03-12 | 2009-03-26 | Epitome Pharmaceuticals Limited | Rapidly absorbing lipophilic skin compositions and uses therefor |
US20040185009A1 (en) * | 2003-03-19 | 2004-09-23 | Dexcel Pharma Technologies Ltd. | Composition and device for treating periodontal diseases |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
BRPI0415741B1 (en) | 2003-11-07 | 2013-07-23 | tobacco compositions and methods of manufacturing a tobacco composition | |
US20050207993A1 (en) * | 2003-11-13 | 2005-09-22 | Russel Bazemore | Method and composition for breath freshening |
PL1750683T3 (en) | 2004-04-23 | 2013-05-31 | Amgen Inc | Sustained release formulations |
CA2649149A1 (en) * | 2006-04-11 | 2007-10-25 | Koko Kosmetikvertrieb Gmbh & Co. Kg | Nanoparticle containing nicotine and/or cotinine, dispersions, and use thereof |
US8642088B2 (en) | 2009-09-04 | 2014-02-04 | Wisconsin Alumni Research Foundation | Tannin-chitosan composites |
KR101307367B1 (en) * | 2010-09-14 | 2013-09-25 | 주식회사 이노테라피 | Adhesive composition comprising tannin, polyethylene glycol, and water, low carbon alcohol or the mixture thereof |
US8865198B2 (en) | 2010-10-25 | 2014-10-21 | Dexcel Pharma Technologies Ltd. | Method for treating a periodontal disease |
FR2972327B1 (en) * | 2011-03-11 | 2017-08-11 | Laboratoires Le Stum | MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION |
GB2496654A (en) * | 2011-11-18 | 2013-05-22 | Reckitt & Colman Overseas | Self-assembling peptides |
US20130158132A1 (en) * | 2011-12-19 | 2013-06-20 | Aida Salatinjants | Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans |
WO2015167257A1 (en) * | 2014-04-29 | 2015-11-05 | 포항공과대학교 산학협력단 | Composition for oral application and method for preparing same |
RU2606589C2 (en) * | 2015-02-16 | 2017-01-10 | Александр Александрович Кролевец | Method of producing tannin nanocapsules |
US10532046B2 (en) * | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
US20220287981A1 (en) * | 2019-08-16 | 2022-09-15 | Amd Pharma Ltd. | Adhesive drug delivery microparticles and a product comprising thereof |
CN115477920A (en) * | 2021-06-15 | 2022-12-16 | 西南大学 | Preparation method of tannin-based underwater adhesive and product |
KR20230146888A (en) | 2022-04-13 | 2023-10-20 | 경북대학교 산학협력단 | Drug sustained-release self-healing coating layer for dental restoration and manufacturing method thereof |
CN117322671A (en) * | 2023-11-01 | 2024-01-02 | 东莞市吉纯生物技术有限公司 | Nicotine liposome and preparation method thereof and electronic atomized liquid |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB104609A (en) * | 1916-06-05 | 1917-03-15 | Monneron & Guye | A Method of Manufacturing a Medicinal Aluminium Preparation. |
GB918754A (en) * | 1959-08-14 | 1963-02-20 | Armour & Co | Improvements in or relating to corticotrophin preparations |
GB2036750B (en) * | 1978-11-23 | 1983-05-05 | Payne M | Tannin complexes |
JPS5846011A (en) * | 1981-09-14 | 1983-03-17 | Kao Corp | Hair treatment |
JPH01166763A (en) * | 1987-12-22 | 1989-06-30 | Nitta Gelatin Inc | Medical and dental curable material |
WO1989010745A1 (en) * | 1988-05-02 | 1989-11-16 | Pomerantz, Edwin | Compositions and in situ methods for forming films on body tissue |
JPH04114655A (en) * | 1990-09-03 | 1992-04-15 | Shinonaga Kasei Kk | Hard composition for medical use |
JPH04312522A (en) * | 1991-04-08 | 1992-11-04 | Yoshiaki Kawashima | Production of sustained release tablet |
JP3496727B2 (en) * | 1993-12-27 | 2004-02-16 | 救急薬品工業株式会社 | Pharmaceutical base |
JPH08319232A (en) * | 1995-03-22 | 1996-12-03 | Takeda Chem Ind Ltd | Particulate composition |
JP2885668B2 (en) * | 1995-09-29 | 1999-04-26 | 沢井製薬株式会社 | Teprenone formulation |
-
1998
- 1998-07-22 CA CA002296654A patent/CA2296654A1/en not_active Abandoned
- 1998-07-22 HU HU0002490A patent/HUP0002490A2/en unknown
- 1998-07-22 JP JP2000503824A patent/JP2001510788A/en not_active Withdrawn
- 1998-07-22 WO PCT/US1998/015096 patent/WO1999004764A1/en not_active Application Discontinuation
- 1998-07-22 BR BR9811478-6A patent/BR9811478A/en not_active Application Discontinuation
- 1998-07-22 IL IL13415198A patent/IL134151A0/en unknown
- 1998-07-22 KR KR1020007000475A patent/KR20010021911A/en not_active Application Discontinuation
- 1998-07-22 EP EP98936955A patent/EP1003483A1/en not_active Withdrawn
- 1998-07-22 AU AU85784/98A patent/AU8578498A/en not_active Abandoned
-
2000
- 2000-01-20 NO NO20000284A patent/NO20000284L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0002490A2 (en) | 2000-12-28 |
EP1003483A1 (en) | 2000-05-31 |
NO20000284L (en) | 2000-03-22 |
CA2296654A1 (en) | 1999-02-04 |
JP2001510788A (en) | 2001-08-07 |
BR9811478A (en) | 2000-08-15 |
KR20010021911A (en) | 2001-03-15 |
AU8578498A (en) | 1999-02-16 |
WO1999004764A1 (en) | 1999-02-04 |
NO20000284D0 (en) | 2000-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL134151A0 (en) | Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity | |
IL123986A0 (en) | Antithombotic agents process for their preparation and pharmaceutical compositions comprising them | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
HUP0201376A2 (en) | Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds | |
HU9800985D0 (en) | Retarde polymere compositions for pharmaceutical compositions | |
EG23875A (en) | Oral pharmaceutical pulsed release dosage form | |
HUP0203542A3 (en) | 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same | |
HUP0001539A3 (en) | 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same | |
IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
EP1043030A4 (en) | Sustained release medicinal compositions | |
HUP0204519A3 (en) | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations | |
IL136938A0 (en) | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
ZA986889B (en) | Controlled release pharmaceutical compositions containing tiagabine | |
GB9713149D0 (en) | Pharmaceutical formulations | |
HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
HUP0202762A3 (en) | Solid lipid compositions, process for their preparation and use thereof | |
AP2000002010A0 (en) | Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof | |
HUP0102215A3 (en) | Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation | |
HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
HUP9803040A3 (en) | Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them | |
EG24463A (en) | Modified release pharmaceutical composition | |
HUP0001093A3 (en) | Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation | |
HUP0105308A3 (en) | Eletriptan hydrobromide monohydrate, process for its preparation and pharmaceutical compositions containing the same | |
HUP0104544A2 (en) | New pharmaceutical composition and the process for its preparation | |
HUP0204444A3 (en) | Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them |